UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

Recent advances in nanomedicine and survivin targeting in brain cancers

Nanomedicine (London, England), 2018-01, Vol.13 (1), p.105-137

2018

Link zum Volltext

Verfügbarkeit prüfen

Chimeric aptamers in cancer cell-targeted drug delivery

Critical reviews in biochemistry and molecular biology, 2011-12, Vol.46 (6), p.459-477

2011

Link zum Volltext

Verfügbarkeit prüfen

Molecular targets in arthritis and recent trends in nanotherapy

International Journal of Nanomedicine, 2015-01, Vol.10, p.5407-5420

2015

Link zum Volltext

Verfügbarkeit prüfen

Multifunctional iron bound lactoferrin and nanomedicinal approaches to enhance its bioactive functions

Molecules, 2015-05, Vol.20 (6), p.9703-9731

2015

Link zum Volltext

Verfügbarkeit prüfen

Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors

International journal of molecular sciences, 2019-08, Vol.20 (17), p.4235

2019

Link zum Volltext

Verfügbarkeit prüfen

EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs

Cancers, 2018-01, Vol.10 (1), p.19

2018

Link zum Volltext

Verfügbarkeit prüfen

Nucleic acid-based aptamers: applications, development and clinical trials

Current medicinal chemistry, 2015-01, Vol.22 (21), p.2539

2015

Link zum Volltext

Verfügbarkeit prüfen

Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents

Journal of nanobiotechnology, 2016-01, Vol.14 (1), p.6-6, Article 6

2016

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents

Journal of nanobiotechnology, 2019-02, Vol.17 (1), p.33-33, Article 33

2019

Link zum Volltext

Verfügbarkeit prüfen

Characterization and Molecular Mechanism of Peptide-Conjugated Gold Nanoparticle Inhibiting p53-HDM2 Interaction in Retinoblastoma

Molecular therapy. Nucleic acids, 2017-12, Vol.9 (C), p.349-364

2017

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum: Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal Haze

Frontiers in pharmacology, 2018-12, Vol.9, p.1434-1434

2018

Link zum Volltext

Verfügbarkeit prüfen

Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cells

Biomicrofluidics, 2015-09, Vol.9 (5), p.054110-054110

2015

Link zum Volltext

Verfügbarkeit prüfen

Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal Haze

Frontiers in pharmacology, 2017-05, Vol.8, p.223-223

2017

Link zum Volltext

Verfügbarkeit prüfen

Ophthalmic Combination of SurR9-C84A and Trichostatin-A Targeting Molecular Pathogenesis of Alkali Burn

Frontiers in pharmacology, 2016-07, Vol.7, p.226-226

2016

Link zum Volltext

Verfügbarkeit prüfen

Survivin Modulators: An Updated Patent Review (2011-2015)

Recent patents on anti-cancer drug discovery, 2016-04, Vol.11 (2), p.152

2016

Link zum Volltext

Verfügbarkeit prüfen

Erratum: “Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cells” [Biomicrofluidics 9(5), 054110 (2015)]

Biomicrofluidics, 2017-07, Vol.11 (4), p.049901-049901

2017

Link zum Volltext

Verfügbarkeit prüfen

LNA aptamer based multi-modal, Fe3O4-saturated lactoferrin (Fe3O4-bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI and CT imaging

Biomaterials, 2015-12, Vol.71, p.84-99

2015

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “LNA aptamer based multi-modal, Fe3 O4 -saturated lactoferrin (Fe3 O4 -bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumour targeting and NIR, MRI and CT imaging” [Biomaterials 71C (2015) 84–99]

Biomaterials, 2017, Vol.138, p.118-120

2017

Link zum Volltext

Verfügbarkeit prüfen

Fe-bLf nanoformulation targets survivin to kill colon cancer stem cells and maintains absorption of iron, calcium and zinc

Nanomedicine (London, England), 2015-01, Vol.10 (1), p.35-55

2015

Link zum Volltext

Verfügbarkeit prüfen

LNA aptamer based multi-modal, Fe 3 O 4 -saturated lactoferrin (Fe 3 O 4 -bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI and CT imaging

Biomaterials, 2015-12, Vol.71, p.84-99

2015

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “LNA aptamer based multi-modal, Fe3O4-saturated lactoferrin (Fe3O4-bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumour targeting and NIR, MRI and CT imaging” [Biomaterials 71C (2015) 84–99]

Biomaterials, 2017-09, Vol.138, p.118-120

2017

Link zum Volltext

Verfügbarkeit prüfen

LNA aptamer based multi-modal, Fe3 O4 -saturated lactoferrin (Fe3 O4 -bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI and CT imaging

Biomaterials, 2015, Vol.71, p.84-99

2015

Link zum Volltext

Verfügbarkeit prüfen

Targeting VEGF with LNA-stabilized G-rich oligonucleotide for efficient breast cancer inhibition

Chemical communications (Cambridge, England), 2015-06, Vol.51 (46), p.9499-9502

2015

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of nanoformulated therapeutics in an ex-vivo bovine corneal irritation model

Toxicology in vitro, 2015-08, Vol.29 (5), p.917-925

2015

Link zum Volltext

Verfügbarkeit prüfen

Oral administration of iron-saturated bovine lactoferrin-loaded ceramic nanocapsules for breast cancer therapy and influence on iron and calcium metabolism

International journal of nanomedicine, 2015-01, Vol.10 (default), p.4081-4098

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(40)
Buchkapitel
(2)

Sprache

Englisch
(42)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Life Sciences & Biomedicine
(23)
Animals
(15)
Humans
(12)
Science & Technology - Other Topics
(12)
Nanoscience & Nanotechnology
(11)
Pharmacology & Pharmacy
(9)
Cancer
(8)
Nanoparticles
(8)
Survivin
(8)
Cattle
(7)
Mice
(7)
Technology
(7)
Apoptosis
(5)
Aptamers, Nucleotide - Chemistry
(5)
Biochemistry & Molecular Biology
(5)
Cell Line, Tumor
(5)
Lactoferrin - Chemistry
(5)
Physical Sciences
(5)
Antineoplastic Agents - Pharmacology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Recent advances in nanomedicine and survivin targeting in brain cancers

Chimeric aptamers in cancer cell-targeted drug delivery

Molecular targets in arthritis and recent trends in nanotherapy

Multifunctional iron bound lactoferrin and nanomedicinal approaches to enhance its bioactive functions

Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors

EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs

Nucleic acid-based aptamers: applications, development and clinical trials

Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents

Correction to: Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents

Characterization and Molecular Mechanism of Peptide-Conjugated Gold Nanoparticle Inhibiting p53-HDM2 Interaction in Retinoblastoma

Corrigendum: Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal Haze

Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cells

Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal Haze

Ophthalmic Combination of SurR9-C84A and Trichostatin-A Targeting Molecular Pathogenesis of Alkali Burn

Survivin Modulators: An Updated Patent Review (2011-2015)

Erratum: “Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cells” [Biomicrofluidics 9(5), 054110 (2015)]

LNA aptamer based multi-modal, Fe3O4-saturated lactoferrin (Fe3O4-bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI and CT imaging

Corrigendum to “LNA aptamer based multi-modal, Fe3 O4 -saturated lactoferrin (Fe3 O4 -bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumour targeting and NIR, MRI and CT imaging” [Biomaterials 71C (2015) 84–99]

Fe-bLf nanoformulation targets survivin to kill colon cancer stem cells and maintains absorption of iron, calcium and zinc

LNA aptamer based multi-modal, Fe 3 O 4 -saturated lactoferrin (Fe 3 O 4 -bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI and CT imaging

Corrigendum to “LNA aptamer based multi-modal, Fe3O4-saturated lactoferrin (Fe3O4-bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumour targeting and NIR, MRI and CT imaging” [Biomaterials 71C (2015) 84–99]

LNA aptamer based multi-modal, Fe3 O4 -saturated lactoferrin (Fe3 O4 -bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI and CT imaging

Targeting VEGF with LNA-stabilized G-rich oligonucleotide for efficient breast cancer inhibition

Evaluation of nanoformulated therapeutics in an ex-vivo bovine corneal irritation model

Oral administration of iron-saturated bovine lactoferrin-loaded ceramic nanocapsules for breast cancer therapy and influence on iron and calcium metabolism

Suchergebnisse filtern